// App-Quantinova.ai

: Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo

Researchers

Presenter

  • Rahul Shrimanker

Principal Investigators

  • Beverley Hargaden

  • Peter Bradding

  • AJ Wardlaw

  • CE Brightling

  • Ruth Green

  • Mona Bafadhel

  • ID Pavord

  • Pranab Haldar

  • L Heaney

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • University of Leeds, Leeds, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved